Insight review articles

Natl Acad. Sci. USA 92, 2780–2784 (1995).
84. Nishikawa, T. et al. Normalizing mitochondrial superoxide production blocks three pathways of
hyperglycaemic damage. Nature 404, 787–790 (2000).
85. Giugliano, D., Ceriello, A. & Paolisso, G. Oxidative stress and diabetic vascular complications.
Diabetes Care 19, 257–267 (1996).
86. Giardino, I., Edelstein, D. & Brownlee, M. BCL-2 expression or antioxidants prevent hyperglycemia-
induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J.
Clin. Invest. 97, 1422–1428 (1996).
87. Korshunov, S. S., Skulachev, V. P. & Starkov, A. A. High protonic potential actuates a mechanism of
production of reactive oxygen species in mitochondria. FEBS Lett. 416, 15–18 (1997).
88. Craven, R. P., Phillip, S. L., Melhem, M. F., Liachenko, J. & De Rubertis, F. R. Overexpression of Mn
2+
superoxide dismutase suppresses increases in collagen accumulation induced by culture in
measangial cells in high media glucose. Metabolism (in the press).
89. Yamagishi, S. I., Edelstein, D., Du, X. L. & Brownlee, M. Hyperglycemia potentiates collagen-induced
platelet activation through mitochondrial superoxide overproduction. Diabetes 50, 1491–1494 (2001).
90. Craven, P. A., Melham, M. F., Phillip, S. L. & DeRubertis, F. R. Overexpression of Cu
2+
/Zn
2+
superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes
50, 2114–2125 (2001).
91. Engerman, R. L. & Kern, T. S. Progression of incipient diabetic retinopathy during good glycemic
control. Diabetes 36, 808–812 (1987).
92. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and
Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four
years after a trial of intensive therapy. N. Engl. J. Med. 342, 381–389 (2000).
93. Quinn, M., Angelico, M. C., Warram, J. H. & Krolewski, A. S. Familial factors determine the
development of diabetic nephropathy in patients with IDDM. Diabetologia 39, 940–945 (1996).
94. The Diabetes Control and Complications Trial Research Group. Clustering of long-term
complications in families with diabetes in the diabetes control and complications trial. Diabetes 46,
1829–1839 (1997).
95. Wagenknecht, L. E. et al. Familial aggregation of coronary artery calcium in families with type 2
diabetes. Diabetes 50, 861–866 (2001).
96. Kowluru, R. A., Tang, J. & Kern, T. S. Abnormalities of retinal metabolism in diabetes and
experimental galactosemia. VII. Effect of long-term administration of antioxidants on the
development of retinopathy. Diabetes 50, 1938–1942 (2001).
97. Ting, H. H. et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-
insulin-dependent diabetes mellitus. J. Clin. Invest. 97, 22–28 (1996).
98. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and
microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-
HOPE substudy. Lancet 355, 253–259 (2000).
99. Salvemini, D. et al. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats.
Science 286, 304–306 (1999).
100.Coppey, L. J. et al. Brit. J. Pharmacol. 134, 21–29 (2001).
Acknowledgements
This work was supported by grants from NIH, Juvenile Diabetes Research Foundation
and American Diabetes Association. Owing to space limitations, a comprehensive list of
reference citations could not be included. I apologize to those colleagues whose work is
not specifically referenced, and gratefully acknowledge their contributions to the field.
insight
review articles
820
NATURE
|
VOL 414
|
13 DECEMBER 2001
|
www.nature.com
© 2001 Macmillan Magazines Ltd